Latest Schedule 13G passive stakes

AQR Capital Management entities report a beneficial ownership of 7.02% in Spark I Acquisition Corp's Class A ordinary shares as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 167,513 ordinary shares, representing 4.99% of Wearable Devices Ltd.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 3,436,000 shares, representing 5.58% of Voyager Therapeutics, Inc.'s common stock, as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting beneficial ownership of 4.99% of Vivos Therapeutics, Inc. common stock as of June 30, 2026.

Howard Lee and associated entities have filed an exit statement for Lucas GC Ltd, reporting beneficial ownership below the 5% threshold.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 7,024,000 shares, representing 7.76% of Verastem, Inc.'s common stock, as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 4,079,129 shares, representing 7.33% of VSee Health, Inc.'s common stock.

Ameriprise Financial and Columbia Management report a combined 10.6% beneficial ownership of Hamilton Beach Brands Holding Company's Class A Common Stock as of June 30, 2026.

Ameriprise Financial and Columbia Management report a combined 10.6% beneficial ownership of Hamilton Beach Brands Holding Company's Class A Common Stock as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 1,572,539 shares, representing 1.67% of the outstanding common stock of Travere Therapeutics, Inc.

Armistice Capital, LLC and Steven Boyd report acquiring a 9.91% beneficial ownership stake in Trevena, Inc., holding 95,000 shares.

Armistice Capital, LLC, along with Steven Boyd, has reported beneficial ownership of 54,554 shares, representing 9.99% of the common stock of Tenon Medical, Inc.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 6,364,000 shares, representing 9.79% of the common stock of Treace Medical Concepts, Inc.

Armistice Capital, LLC and Steven Boyd have jointly reported a beneficial ownership of 9.99% in Stryve Foods, Inc. Class A Common Stock.

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 9.38% of Sangamo Therapeutics, Inc.'s common stock, filing as a Schedule 13G.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 3,328,000 shares, representing 7.29% of Rapid Micro Biosystems, Inc.'s Class A common stock.

Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, reporting a beneficial ownership of 9.99% in Arcadia Biosciences, Inc.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 1,672,000 shares, representing 8.95% of Rigel Pharmaceuticals, Inc.'s common stock, as of June 30, 2026.

Ameriprise Financial, Inc. and its subsidiary Ameriprise Financial Services, LLC have reported beneficial ownership of 6.7% of Nuveen Mortgage and Income Fund's common stock.

Ameriprise Financial, Inc. and its subsidiary Ameriprise Financial Services, LLC have reported beneficial ownership of 6.7% of Nuveen Mortgage and Income Fund's common stock.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting beneficial ownership of 4.99% of Revelation Biosciences, Inc. common stock.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 83,769 shares, representing 9.99% of PowerCompute, Inc.'s common stock.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 1,531,152 shares, representing 8.58% of The OLB Group, Inc.'s common stock.

Skandinaviska Enskilda Banken AB (publ) has filed a Schedule 13G, disclosing beneficial ownership of 5.3% of Autoliv Inc.'s common stock represented by Swedish Depositary Receipts.

Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,264,000 shares, representing 8.01% of Orthofix Medical Inc.'s common stock.

Armistice Capital, LLC and Steven Boyd have updated their beneficial ownership filing for Nuwellis, Inc., reporting a 4.99% stake.

Armistice Capital, LLC, along with its managing member Steven Boyd, has reported beneficial ownership of 7.88% of MacroGenics, Inc. common stock as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 3,372,000 shares, representing 7.57% of Li-Cycle Holdings Corp.'s common stock.

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Tripadvisor, Inc. common stock.

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Tripadvisor, Inc. common stock.